We have solutions for Pharma and Biotech
Heligenics is disrupting and redefining the way genetic information is used in the creation of new drugs at multiple steps along the drug development pipeline. Use our GMLs pre-clinically to minimize adverse events and non-responders before an expensive clinical trial. Our super-precision genetic-based trial design increases safety and efficacy, producing desired outcomes for all phases of a clinical trial.
Redesign a failed clinical trial into a targeted precision trial. Repurpose a drug to maximize profits with our receptor activation maps to experimentally identify off-target receptors and new indications.
Unlock value from previous investment to the company’s bottom line.
Our Pharma & Biotech Solutions

Our super-precision genetic-based design increasing safety and efficacy in producing successful outcomes

Our GMLs enables activation of major signaling pathways or cell toxicity to be measured
